Table 3.

Correlation between RECK expression and various clinicopathological features in breast cancer patients

Variables	No. of cases	RECK
		Negative	Positive	P‐value
Age (years)
<50	60	31	29	0.855
≥50	59	32	27
Tumor size
pT1	40	16	24	0.080
pT2–T4	79	46	33
Menopausal status
Premenopausal	67	35	32	1.000
Postmenopausal	52	28	24
Histologic grade
G1	13	2	11	0.006
G2–G3	106	61	45
Lymph node status
N0	54	20	34	0.002
N1–N3	65	43	22
ER status
Positive	73	38	35	0.852
Negative	46	25	21
PR status
Positive	67	36	31	0.855
Negative	52	27	25
HER‐2 status
Positive (IHC 3+)	18	7	11	0.573
Negative (IHC 1+)	92	35	57
Adjuvant systemic therapy
Yes	80	42	38	1.000
No	39	21	18

ER, estrogen receptor; NPI, Nottingham prognostic index; PR, progesterone receptor.